Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Hitachi Rail announced an investment of almost C$30 million in a new state-of-the-art Canadian headquarters in Toronto, OntarioThe new 5.5 floor HQ to be home to 1,100 highly-skilled employees at...
-
NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will...
-
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA2, marking its twelfth consecutive half-year of positive Adjusted EBITDA. Revenue for 2025...
-
MONTRÉAL, 19 févr. 2026 (GLOBE NEWSWIRE) -- HPQ Silicium Inc. (« HPQ » ou la « Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), entreprise technologique spécialisée dans l’innovation en...
-
HPQ secures first 50 kg fumed silica order as pilot plant meets core specs, advancing customer testing and proposed 1,000 TPY JV plans.
-
MONTRÉAL, 19 févr. 2026 (GLOBE NEWSWIRE) -- Supremex inc. (« Supremex » ou la « Société ») (TSX : SXP), chef de file nord‑américain dans la fabrication et la distribution d’enveloppes...
-
REDWOOD CITY, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation in the...
-
19. veebruaril 2026 toimus AS-i Tallink Grupp veebiseminar, kus juhatuse esimees Paavo Nõgene ja juhatuse liikmed Harri Hanschmidt ning Margus Schults tutvustasid 2025. aasta neljanda kvartali ja 12...
-
On 19 February 2026 AS Tallink Grupp held an investor webinar where Paavo Nõgene, the Chairman of the Management Board, Harri Hanschmidt and Margus Schults, the Members of the Management Board...
-
Oxford, UK and Boston, MA – February 19, 2026 – Sitryx Therapeutics (“the Company”), a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in autoimmune...